NCT04707235 ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04694976 Vitamin D Status in Children With Sickle Cell Disease Living in Lyon, France Status COMPLETED Phase N/A
NCT04691323 The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04688411 An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease Status RECRUITING Phase NA
NCT04684381 Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients Status COMPLETED Phase PHASE4
NCT04678037 Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study Status COMPLETED Phase NA
NCT04675645 Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App Status COMPLETED Phase NA
NCT04667325 Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients Status COMPLETED Phase N/A
NCT04657822 Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study Status RECRUITING Phase PHASE4
NCT04629430 Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT Status COMPLETED Phase NA
NCT04628585 Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy Status ENROLLING_BY_INVITATION Phase N/A
NCT04624659 A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04614610 Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis Status UNKNOWN Phase PHASE2
NCT04610866 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04606160 Utilizing A Single Session Problem-Solving Intervention With Caregivers of Pediatric Patients Receiving Chronic Transfusion to Treat Sickle Cell Disease Status COMPLETED Phase NA
NCT04594031 US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease Status WITHDRAWN Phase PHASE1
NCT04587661 Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment Status TERMINATED Phase NA